PTSD

News

ICER raps conduct of Lykos’ psychedelic trial for PTSD

The Institute for Clinical and Economic Review (ICER) typically focuses on the cost-effectiveness of new therapies, but in an unusual move has sharply criticised the desig

News

FDA sets June adcomm date for Lilly’s Alzheimer’s drug

The FDA has confirmed that it will convene an advisory committee meeting on 10th June to discuss Eli Lilly’s Alzheimer’s disease candidate donanemab, after announcing a de

News

Australia first to prescribe MDMA and psilocybin for depress...

On 1st July, Australia became the first country to allow

News

Otsuka backs GrayMatters' digital wearable tech for mental d...

Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital he

Digital

Re-envisioning mental health treatment using clinical VR

Skip Rizzo, PhD, research director for medical virtual reality at the University of Southern California's Institute for Creative Technologies (USC ICT), tells us how its virtual reality (VR

News

MDMA on track for 2023 approval as PTSD therapy, says develo...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the org

ICER raps conduct of Lykos’ psychedelic trial for PTSD

FDA sets June adcomm date for Lilly’s Alzheimer’s drug

Australia first to prescribe MDMA and psilocybin for depress...

Otsuka backs GrayMatters' digital wearable tech for mental d...

Re-envisioning mental health treatment using clinical VR

MDMA on track for 2023 approval as PTSD therapy, says develo...

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

PTSD

Editor's Picks